The goal of this clinical trial is to compare the quality of corneal grafts cultured in a serum-free culture medium with a defined composition versus corneal grafts cultured in a standard serum supplemented culture medium transplanted in patients with decompensated corneal dystrophy
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The primary outcome is the endothelial cell density of the corneal grafts prior to and after the transplantation procedure
Timeframe: The measurment will be performed prior to and 1, 4, 12, 24, 36, 48 and 60 months after the transplantation